Equities, Investment & Market Trends
US Hemp Regulation Bill Faces Opposition from Alcohol, Marijuana, and Prohibitionist Groups
A proposed US hemp regulation bill, the Lawful Hemp Protection Act, faces opposition from alcohol, marijuana, and prohibitionist groups. Understand the le…
Access & Prescribing (Australia & Global)
Medicare Initiative Explores CBD Access for Older Adults in Select Health Networks
A new Medicare initiative is exploring CBD access for older adults within Accountable Care Organizations, aiming to assess its impact on quality of life a…
Access & Prescribing (Australia & Global)
Alabama Medical Cannabis Sales Imminent as First Dispensary Prepares to Open
Alabama's medical cannabis program is set to launch, with the first dispensary opening soon. Learn about patient access, qualifying conditions, and produc…
As cannabis use rises among older adults, Stanford Medicine experts detail five significant health risks, including increased potency, heart issues, and d…
Clinical Trials & Medical Research
New Review Explores Cannabidiol’s Potential as an Anticancer Agent for Dogs
A new scientific review suggests cannabidiol (CBD) may offer therapeutic potential as an anticancer agent for dogs, inhibiting cell growth and promoting c…
Access & Prescribing (Australia & Global)
Senator Fetterman Commends Federal Cannabis Rescheduling and Therapeutic Psychedelics Initiatives
Senator John Fetterman (D-PA) has lauded federal cannabis rescheduling efforts and moves to expand therapeutic psychedelics access, signaling bipartisan s…
Access & Prescribing (Australia & Global)
US Congress Advances Medical Cannabis Access for Veterans Amidst Broader Policy and Market Developments
Explore significant US federal and state policy shifts impacting medical cannabis access, including veteran prescribing and hospital use, alongside Austra…
Access & Prescribing (Australia & Global)
EU Agency Classifies CBD as Reproductive Toxicant, Threatening European Cosmetics and Supplement Markets
The European Chemicals Agency (ECHA) has classified CBD as a reproductive toxicant, potentially reshaping the European CBD market. Understand the regulato…
Equities, Investment & Market Trends
European Parliament Committee Backs Farm Supports for Hemp Flowers Amidst Contracting CBD Market
A European Parliament committee has approved extending farm supports to hemp flowers, impacting EU hemp regulations and the CBD market. Learn about the le…
Access & Prescribing (Australia & Global)
U.S. Department of Justice Reschedules Medical Cannabis to Schedule III, Initiates Broader Review
The U.S. Department of Justice has issued a final order rescheduling medical cannabis to Schedule III, impacting FDA-approved products and state-licensed…
